Susan ALTSCHULLER
CIK 1817988 · Chief Financial Officer · last filed 2026-01-08
Susan ALTSCHULLER is a Chief Financial Officer who has filed 14 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for ELYM, was dated Jan 8, 2026. Across all open-market trades the lifetime net is −$539.9K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
14
-$539.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Climb Bio, Inc. (ELYM) Delisted | Chief Financial Officer | — | $5.11 | — | $0 | 2 | 2026-01-08 |
| Mural Oncology plc (MURAV) Delisted | Director | 10,000 | — | — | $32.1K | 4 | 2024-08-15 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Chief Financial Officer | 30,721 | $44.96 | $1.38M | -$572.0K | 3 | 2024-01-23 |
| ImmunoGen, Inc. (IMGN) Delisted | SVP AND CFO | — | $31.23 | — | $0 | 4 | 2022-12-27 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-08 | Climb Bio, Inc. (ELYM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-10-01 | Climb Bio, Inc. (ELYM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-15 | Mural Oncology plc (MURAV) Delisted | Buy (P) | +10,000 | $32.1K | EDGAR |
| 2024-08-05 | — | Disp (D) | −16,913 | $0 | |
| 2024-06-05 | Mural Oncology plc (MURAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-03 | Mural Oncology plc (MURAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-23 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-21 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | +16,913 | -$572.0K | EDGAR |
| 2023-12-18 | Mural Oncology plc (MURAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |